You are here

Article info

Article menu

Download PDFPDF

Clinical science
Long-term follow-up of cystinosis patients treated with 0.55% cysteamine hydrochloride

Authors

  • Hong Liang Sorbonne Universités, INSERM, CNRS, Institut de la Vision, Paris, France PubMed articlesGoogle scholar articles
  • Antoine Labbé Sorbonne Universités, INSERM, CNRS, Institut de la Vision, Paris, France CHNO des Quinze-Vingts, IHU FOReSIGHT, INSERM-DGOS CIC 1423, Paris, France Department of Ophthalmology, Hôpital Ambroise Paré, AP-HP, Université Versailles St Quentin en Yvelines, Montigny-Le-Bretonneux, 78180, France PubMed articlesGoogle scholar articles
  • Christophe Baudouin Sorbonne Universités, INSERM, CNRS, Institut de la Vision, Paris, France CHNO des Quinze-Vingts, IHU FOReSIGHT, INSERM-DGOS CIC 1423, Paris, France Department of Ophthalmology, Hôpital Ambroise Paré, AP-HP, Université Versailles St Quentin en Yvelines, Montigny-Le-Bretonneux, 78180, France PubMed articlesGoogle scholar articles
  • Celine Plisson Recordati Rare Diseases, Puteaux, Puteaux, France PubMed articlesGoogle scholar articles
  • Vincenzo Giordano Recordati Rare Diseases, Puteaux, Puteaux, France PubMed articlesGoogle scholar articles
  1. Correspondence to DrHong Liang, Department of Ophthalmology III, Quinze-Vingts National Ophthalmology Hospital, 28, Rue De Charenton, 75012 Paris, France; lianghongfr{at}yahoo.fr
View Full Text

Citation

Liang H, Labbé A, Baudouin C, et al
Long-term follow-up of cystinosis patients treated with 0.55% cysteamine hydrochloride
British Journal of Ophthalmology 2021;105:608-613.

Publication history

  • Received April 1, 2020
  • Revised May 5, 2020
  • First published June 27, 2020.
Online issue publication 
May 20, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.